Study guide
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics
Key Takeaways Explain This Topic AI
The left anterior descending (LAD) artery supplies 45–55% of the left ventricular myocardium, including the anterior wall and anterior two-thirds of the interventricular septum, making acute proximal occlusion ('widowmaker') the highest risk for cardiogenic shock and conduction defects.
Because myocardial tissue compressive forces during systole exceed intra-aortic pressures, over 80% of left ventricular coronary perfusion occurs during diastole; exertional tachycardia critically truncates diastolic filling and perfusion time.
Coronary artery dominance is determined by the origin of the posterior descending artery (PDA): approximately 85% of the population is right-dominant (PDA arises from the RCA), 10% is left-dominant (from the LCx), and 5% is co-dominant.
Normal resting cardiac output ranges from 4.0 to 8.0 L/min (Cardiac Index 2.5–4.0 L/min/m²), driven by stroke volume (60–100 mL/beat) and heart rate, with normal left ventricular ejection fraction defined as 55% to 70%.
The Rate Pressure Product (RPP = [HR × SBP] / 100) serves as a direct clinical surrogate for myocardial oxygen consumption (MVO₂), establishing a reproducible hemodynamic ischemic threshold during exercise testing and training.
Last updated: September 2026
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics
Cardiovascular rehabilitation professionals require a rigorous foundation in cardiac anatomy, coronary topography, and cardiovascular hemodynamics. Clinical exercise prescription, continuous telemetry monitoring, and acute symptom evaluation all depend upon a precise understanding of myocardial blood supply and mechanical pump function.
Cardiac Chamber Architecture & Valve Dynamics
The human heart operates as two coordinated in-series muscular pumps separated by the central fibrous skeleton. The right heart operates within a low-pressure, high-capacitance pulmonary circuit, whereas the left heart powers a high-pressure, high-resistance systemic circuit.
Right Atrium (RA): Receives systemic venous return from the superior vena cava, inferior vena cava, and coronary sinus. Normal mean resting pressure is 2–6 mmHg . The RA contains the sinoatrial (SA) node at the superior vena caval junction and the fossa ovalis on the interatrial septum.
Right Ventricle (RV): A crescent-shaped chamber that wraps around the anterior left ventricle. Its free wall is relatively thin (3–5 mm). Peak RV systolic pressure normally ranges between 15–25 mmHg , with an end-diastolic pressure of 0–8 mmHg . The RV ejects blood through the pulmonary valve into the low-resistance pulmonary vascular bed (mean pulmonary artery pressure: 10–20 mmHg ).
Left Atrium (LA): Receives oxygenated blood from four pulmonary veins. Normal mean LA pressure is 6–12 mmHg (mirrored clinically by pulmonary capillary wedge pressure, or PCWP). LA enlargement is a major predisposing substrate for atrial fibrillation.
Left Ventricle (LV): A conical, thick-walled muscular chamber (8–12 mm in diastole). Normal LV peak systolic pressure is 100–130 mmHg , with an end-diastolic pressure (LVEDP) of 4–12 mmHg . The LV generates the mechanical force necessary to overcome systemic afterload.
Heart Valve Architecture & Auscultatory Correlates
Cardiac valves maintain unidirectional flow and are classified into two structural groups:
Atrioventricular (AV) Valves: The tricuspid valve (three leaflets: anterior, posterior, septal) separates the RA and RV. The mitral (bicuspid) valve (two leaflets: anterior and posterior) separates the LA and LV. Leaflets are tethered to subvalvular chordae tendineae , which originate from ventricular papillary muscles . Papillary muscle contraction during ventricular systole tensions the chordae, preventing leaflet eversion (prolapse) into the atria. Mitral valve closure produces the first heart sound (S1) .
Semilunar Valves: The pulmonic valve (three cusps: anterior, left, right) and the aortic valve (three pocket-like cusps: right coronary, left coronary, non-coronary). Closure of the semilunar valves when ventricular pressure falls below arterial pressure at the onset of diastole produces the second heart sound (S2) . Physiological splitting of S2 occurs during inspiration because increased venous return delays RV ejection and pulmonic valve closure ( P 2 P_2 P 2 ), widening the interval from aortic closure ( A 2 A_2 A 2 ).
The Pericardium: Biomechanics & Pathology
The heart is enclosed within the pericardium , a fibroserous sac consisting of an outer tough fibrous pericardium and an inner two-layered serous pericardium :
Parietal layer: Lines the internal surface of the fibrous pericardium.
Visceral layer (Epicardium): Firmly adheres to the epicardial myocardial surface.
Pericardial space: Contains 15–50 mL of clear transudative pericardial fluid that eliminates friction during cardiac excursion.
Clinical Pericardial Syndromes in Rehabilitation
Acute Pericarditis: Inflammation characterized by sharp, pleuritic retrosternal chest pain that worsens when supine and improves when leaning forward. A high-pitched, scratchy pericardial friction rub is audible at the left sternal border. Electrocardiography (ECG) reveals hallmark widespread concave ST-segment elevation with reciprocal PR depression in lead aVR.
Cardiac Tamponade: Accumulation of excess fluid under high pressure compromises ventricular diastolic filling. Signs follow Beck's triad : hypotension, jugular venous distention (JVD), and muffled heart sounds. Pulsus paradoxus —an abnormal inspiratory drop in systolic blood pressure exceeding 10 mmHg —is pathognomonic. Tamponade is an absolute emergency contraindicating exercise.
Cardiac Conduction Hierarchy & Electrophysiology
Synchronized myocardial contraction depends upon a specialized, non-contractile conduction system:
Sinoatrial (SA) Node: Located in the epicardial groove at the junction of the superior vena cava and the high lateral right atrium. As the primary pacemaker, its intrinsic depolarization rate is 60–100 bpm due to spontaneous phase 4 diastolic depolarization mediated by pacemaker funny channels ( I f I_f I f ).
Internodal Pathways: Depolarization propagates across the RA via anterior (Bachmann), middle (Wenckebach), and posterior (Thorel) tracts. Bachmann's bundle crosses the interatrial septum to activate the left atrium.
Atrioventricular (AV) Node: Located subendocardially in the inferior right atrium at the apex of the triangle of Koch (bounded by the coronary sinus ostium, the septal tricuspid leaflet, and the tendon of Todaro). The AV node conducts slowly, introducing a physiological delay of 0.09–0.12 seconds . This pause allows complete atrial mechanical emptying ("atrial kick") to maximize end-diastolic ventricular filling. The intrinsic AV junctional pacemaker rate is 40–60 bpm .
Bundle of His & Bundle Branches: Depolarization rapidly crosses the non-conductive atrioventricular fibrous trigone via the Bundle of His. It bifurcates into the Right Bundle Branch (RBB) and the broader Left Bundle Branch (LBB) . The LBB divides into a thin left anterior fascicle (traversing anterior LV) and a stout, dual-blood-supplied left posterior fascicle (traversing posterior-inferior LV).
Purkinje Fiber Network: Extensive subendocardial arborization exhibiting conduction velocities of 2–4 m/s (the fastest in the heart). This ensures near-instantaneous depolarization of ventricular myocardium from the endocardium outward and from the apex toward the base, optimizing mechanical ejection. The Purkinje network possesses an intrinsic escape rate of 20–40 bpm .
Coronary Artery Topography & Vascular Territories
The coronary arterial tree originates from the aortic root immediately superior to the aortic valve cusps at the sinuses of Valsalva . [Aortic Root]
- / \
- [Left Main / LMCA] [Right Coronary / RCA]
- / \ |-- Conus & Sinoatrial Nodal (60%)
- / \ |-- Acute Marginal Branches (RV)
- [LAD] [LCx] |-- AV Nodal Artery (90%)
- |-- Diagonals (LV) |-- Obtuse Marginals (OM) \-- Posterior Descending (PDA, 85%)
- \-- Septals (2/3) \-- Posterolateral (PL)
- Left Main Coronary Artery (LMCA) & Branches
The LMCA arises from the left aortic sinus, coursing between the pulmonary trunk and left atrial appendage before bifurcating into the LAD and LCx:
Left Anterior Descending (LAD) Artery: Known colloquially as the "widowmaker." Travels down the anterior interventricular groove toward the apex. It provides:
Diagonal branches: Supply the anterolateral left ventricular free wall.
Septal perforators: Penetrate deeply to supply the anterior two-thirds of the interventricular septum , including the bundle of His and bundle branches.
Territory: Anterior wall, anteroseptal myocardium, cardiac apex, and bundle branch conduction system. Occlusion yields extensive anterior/septal STEMI (leads V1–V4), carrying high risk of acute pump failure, cardiogenic shock, and bundle branch block.
Left Circumflex (LCx) Artery: Courses along the coronary sulcus around the left cardiac border to the posterior surface. Gives off:
Obtuse Marginal (OM) branches: Supply the lateral and posterolateral LV myocardium and the anterolateral papillary muscle.
Territory: Lateral and high lateral LV wall (leads I, aVL, V5, V6).
Right Coronary Artery (RCA) & Dominance
The RCA arises from the right aortic sinus, coursing down the anterior right atrioventricular groove:
Conus artery & Sinoatrial (SA) Nodal Branch: Supplies the SA node in 60% of human hearts (the LCx supplies it in the remaining 40%).
Acute Marginal Branches: Supply the right ventricular free wall.
Atrioventricular (AV) Nodal Branch: Arises at the crux of the heart to supply the AV node in 90% of human hearts.
Posterior Descending Artery (PDA): Runs in the posterior interventricular groove supplying the inferior wall of the LV and the posterior third of the interventricular septum .
Coronary Dominance Patterns
Coronary dominance is defined strictly by the artery giving origin to the posterior descending artery (PDA) and posterolateral branches:
Right-Dominant (85% of population): PDA arises from the distal RCA.
Left-Dominant (10% of population): PDA arises from the distal LCx.
Co-Dominant (5% of population): RCA supplies the PDA, while the LCx supplies a parallel posterior descending or large posterolateral branch.
Clinical Exam Tip: Because the RCA supplies the inferior myocardium (leads II, III, aVF) and the AV node in 90% of individuals, inferior STEMI is frequently accompanied by vagally mediated or ischemic sinus bradycardia, Mobitz I (Wenckebach) AV block , or complete third-degree AV block.
Coronary Perfusion Physiology & Diastolic Mechanics
Unlike all other systemic vascular beds, myocardial blood flow in the left ventricle occurs predominantly during ventricular diastole : Coronary Perfusion Pressure (CPP) = Aortic Diastolic Pressure (AoDP) − Left Ventricular End-Diastolic Pressure (LVEDP) \text{Coronary Perfusion Pressure (CPP)} = \text{Aortic Diastolic Pressure (AoDP)} - \text{Left Ventricular End-Diastolic Pressure (LVEDP)} Coronary Perfusion Pressure (CPP) = Aortic Diastolic Pressure (AoDP) − Left Ventricular End-Diastolic Pressure (LVEDP)
Systolic Extravascular Compression: During ventricular systole, myocardial contraction generates high intramyocardial tissue compressive forces. In the subendocardium of the LV, tissue pressure approaches or exceeds intracavitary pressure (~120 mmHg), compressing and occluding intramural capillaries. Consequently, >80% of left ventricular coronary blood flow occurs during diastole .
Tachycardia & Diastolic Curtailment: At resting heart rates (60–70 bpm), diastole comprises approximately two-thirds (~65%) of the cardiac cycle, and systole comprises one-third. With exertional tachycardia (e.g., 140–160 bpm), diastolic duration shortens disproportionately to less than 35% of each cycle. This precipitous drop in diastolic filling time drastically curtails coronary perfusion time precisely when metabolic oxygen demand ( M V O 2 MVO_2 M V O 2 ) surges.
Subendocardial Ischemia Vulnerability: The subendocardium is the most metabolically demanding and mechanically compressed layer, rendering it the first zone to become ischemic when coronary driving pressure falls or downstream stenoses prevent compensatory autoregulation.
Cardiovascular Hemodynamics: Formulas & Clinical Calculations
Rehabilitation clinicians regularly calculate and interpret hemodynamic parameters during diagnostic testing and exercise sessions:
1. Cardiac Output (CO) & Cardiac Index (CI) CO = Heart Rate (HR) × Stroke Volume (SV) \text{CO} = \text{Heart Rate (HR)} \times \text{Stroke Volume (SV)} CO = Heart Rate (HR) × Stroke Volume (SV)
Normal Resting CO: 4.0 to 8.0 L/min .
During maximal aerobic exercise in healthy trained individuals, CO can rise to 20–35 L/min , mediated by increases in both HR and SV.
Cardiac Index (CI): Standardizes CO to Body Surface Area (BSA in m 2 m^2 m 2 ): CI = CO BSA ( Normal: 2.5 – 4.0 L/min/m 2 ) \text{CI} = \frac{\text{CO}}{\text{BSA}} \quad (\text{Normal: } 2.5\text{--}4.0\text{ L/min/m}^2) CI = BSA CO ( Normal: 2.5 – 4.0 L/min/m 2 )
A CI < 2.2 L/min/m 2 <2.2\text{ L/min/m}^2 < 2.2 L/min/m 2 indicates cardiogenic hypoperfusion.
2. Stroke Volume (SV) & Ejection Fraction (EF) SV = End-Diastolic Volume (EDV) − End-Systolic Volume (ESV) \text{SV} = \text{End-Diastolic Volume (EDV)} - \text{End-Systolic Volume (ESV)} SV = End-Diastolic Volume (EDV) − End-Systolic Volume (ESV)
Normal SV: 60 to 100 mL/beat . EF (%) = ( SV EDV ) × 100 = ( EDV − ESV EDV ) × 100 \text{EF (\%)} = \left( \frac{\text{SV}}{\text{EDV}} \right) \times 100 = \left( \frac{\text{EDV} - \text{ESV}}{\text{EDV}} \right) \times 100 EF (%) = ( EDV SV ) × 100 = ( EDV EDV − ESV ) × 100
Normal EF: 55% to 70% (indicates normal resting systolic function).
3. Determinants of Stroke Volume: Preload, Afterload, Inotropy
Preload: The resting wall tension or stretch exerted on cardiomyocytes at the end of diastole, clinically reflected by EDV or LVEDP. Under the Frank-Starling law , increased venous return stretches sarcomeres toward their optimal length (~2.2 μ m \mu m μ m ), expanding actin-myosin overlap and augmenting contractility and stroke volume up to a physiological ceiling.
Afterload: The resistance or impedance against which the ventricle must eject blood during systole, clinically reflected by Systemic Vascular Resistance (SVR) and mean arterial pressure. According to the Law of Laplace : Myocardial Wall Stress ( σ ) = P × r 2 h \text{Myocardial Wall Stress} (\sigma) = \frac{P \times r}{2h} Myocardial Wall Stress ( σ ) = 2 h P × r
(where P P P is intraventricular pressure, r r r is ventricular internal radius, and h h h is wall thickness). Elevated afterload (e.g., severe hypertension, aortic stenosis) increases wall stress and oxygen demand, retarding stroke volume.
Contractility (Inotropy): The intrinsic velocity and force of myocardial fiber shortening independent of preload and afterload, driven by intracellular calcium transient availability.
4. Rate Pressure Product (RPP) / Double Product RPP = Heart Rate (bpm) × Systolic Blood Pressure (mmHg) \text{RPP} = \text{Heart Rate (bpm)} \times \text{Systolic Blood Pressure (mmHg)} RPP = Heart Rate (bpm) × Systolic Blood Pressure (mmHg)
(Often divided by 100 for clinical charting: [ HR × SBP ] / 100 [\text{HR} \times \text{SBP}] / 100 [ HR × SBP ] /100 ).
Normal Range: Resting RPP is typically 7,000–12,000 (70–120); peak exercise RPP exceeds 25,000 (>250).
Clinical Significance: RPP correlates linearly with Myocardial Oxygen Consumption ( M V O 2 MVO_2 M V O 2 ) . In patients with stable coronary disease, myocardial ischemia develops at a consistent, highly reproducible RPP—the ischemic threshold . Exercise training heart rates must be prescribed at least 10 beats per minute below the heart rate at which ischemia occurs.
Hemodynamic & Coronary Vascular Comparison Table
Vessel / Structure Primary Myocardial Territory Characteristic ECG Leads Frequent Arrhythmic / Hemodynamic Complications
Left Anterior Descending (LAD) Anterior LV wall, anterior 2/3 interventricular septum, apex V1, V2, V3, V4 Cardiogenic shock, complete RBBB, Mobitz II AV block, anterior LV apical aneurysm
Left Circumflex (LCx) High lateral and posterolateral LV wall, anterolateral papillary muscle I, aVL, V5, V6 Lateral ischemia, acute mitral regurgitation (papillary muscle dysfunction)
Right Coronary Artery (RCA) Inferior LV wall, RV free wall, posterior 1/3 septum II, III, aVF Sinus bradycardia, junctional escape, Mobitz I (Wenckebach) AV block, RV infarction (hypotension)
Posterior Descending (PDA) Inferior/posterior base of LV, posterior interventricular septum II, III, aVF (posterior leads V7–V9) Inferoposterior infarction, true posterior wall ST depression (V1–V3)
Clinical Application: Exercise Prescription at the Ischemic Threshold
A 63-year-old post-CABG patient demonstrates exercise-induced horizontal ST depression (1.5 mm) at a heart rate of 134 bpm and blood pressure of 164/88 mmHg during an intake graded exercise test:
Ischemic RPP Calculation: 134 × 164 = 21 , 976 134 \times 164 = 21,976 134 × 164 = 21 , 976 (or 219.8).
Prescription Directive: The maximum training heart rate for endurance conditioning must be capped at 134 − 10 = 124 bpm 134 - 10 = \mathbf{124\text{ bpm}} 134 − 10 = 124 bpm to maintain an adequate safety margin below the ischemic threshold.
Patient Education: Counsel the patient to avoid sudden isometric straining or upper-extremity overhead loads that cause rapid surges in systolic blood pressure, as sudden pressure spikes accelerate RPP toward the ischemic threshold even at modest heart rates.